BIOMAT Database Logo BIOMAT Database Logo

Presinusoidal portal hypertension at Baragwanath Hospital. 1988

M C Modiba, and D Pantanowitz, and J Franklin

UI MeSH Term Description Entries
D006975 Hypertension, Portal Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN. Cruveilhier-Baumgarten Disease,Cruveilhier-Baumgarten Syndrome,Cruveilhier Baumgarten Disease,Cruveilhier Baumgarten Syndrome,Disease, Cruveilhier-Baumgarten,Portal Hypertension,Portal Hypertensions,Syndrome, Cruveilhier-Baumgarten
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012597 Sclerosing Solutions Chemical agents injected into blood vessels and lymphatic sinuses to shrink or cause localized THROMBOSIS; FIBROSIS, and obliteration of the vessels. This treatment is applied in a number of conditions such as VARICOSE VEINS; HEMORRHOIDS; GASTRIC VARICES; ESOPHAGEAL VARICES; PEPTIC ULCER HEMORRHAGE. Injections, Sclerosing,Sclerosant,Sclerosing Agent,Sclerosing Agents,Sclerosing Injection,Sclerosing Solution,Sclerosants,Sclerosing Drugs,Sclerosing Injections,Agent, Sclerosing,Agents, Sclerosing,Drugs, Sclerosing,Injection, Sclerosing,Solution, Sclerosing,Solutions, Sclerosing
D013164 Splenorenal Shunt, Surgical Anastomosis of splenic vein to renal vein to relieve portal hypertension. Shunt, Surgical Splenorenal,Splenorenal Shunt,Surgical Splenorenal Shunt,Shunt, Splenorenal,Shunts, Splenorenal,Shunts, Surgical Splenorenal,Splenorenal Shunts,Splenorenal Shunts, Surgical,Surgical Splenorenal Shunts

Related Publications

M C Modiba, and D Pantanowitz, and J Franklin
Schistosomiasis and presinusoidal portal hypertension.
November 2001, Endoscopy,
M C Modiba, and D Pantanowitz, and J Franklin
β-Blockers Improve Presinusoidal Portal Hypertension.
November 2018, Digestive diseases and sciences,
M C Modiba, and D Pantanowitz, and J Franklin
Idiopathic presinusoidal portal hypertension (Banti's syndrome).
April 1962, Annals of internal medicine,
M C Modiba, and D Pantanowitz, and J Franklin
A model of presinusoidal portal hypertension.
February 1989, Hepatology (Baltimore, Md.),
M C Modiba, and D Pantanowitz, and J Franklin
Presinusoidal portal hypertension secondary to portal invasive echinococcosis.
January 2002, Journal of clinical gastroenterology,
M C Modiba, and D Pantanowitz, and J Franklin
Presinusoidal portal hypertension in non-alcoholic cirrhosis.
January 1985, Hepatology (Baltimore, Md.),
M C Modiba, and D Pantanowitz, and J Franklin
[Hypersplenism in the presinusoidal portal hypertension syndrome].
January 1978, Revista de chirurgie, oncologie, radiologie, o.r.l., oftalmologie, stomatologie. Chirurgie,
M C Modiba, and D Pantanowitz, and J Franklin
[Presinusoidal portal hypertension in post-hepatitis cirrhosis].
January 1983, Annales de medecine interne,
M C Modiba, and D Pantanowitz, and J Franklin
Surgical treatment of non-cirrhotic presinusoidal portal hypertension.
January 2004, Hepato-gastroenterology,
M C Modiba, and D Pantanowitz, and J Franklin
Gastric motility in patients with presinusoidal portal hypertension.
December 2002, The American journal of gastroenterology,
Copied contents to your clipboard!